<DOC>
	<DOCNO>NCT01417312</DOCNO>
	<brief_summary>This study aim investigate metabolic effect standardize green tea extract , contain defined amount epigallocatechin-3-gallate ( EGCG ) , multiple sclerosis patient .</brief_summary>
	<brief_title>Metabolic Effects Green Tea Extract Multiple Sclerosis Patients</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<criteria>Patients relapsingremitting multiple sclerosis stable treatment glatiramer acetate least 6 month prior inclusion Expanded disability status scale &lt; 4.5 Normal weight , overweight Primary secondary progressive form multiple sclerosis Clinically relevant heart , lung , liver , kidney disease Habitual caffeine intake 300 mg per day Habitual consumption green tea Alcohol drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Multiple sclerosis</keyword>
	<keyword>Green tea extract</keyword>
	<keyword>Metabolism</keyword>
</DOC>